Belluscura (LSE:BELL) Other Current Liabilities : £0.00 Mil (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Belluscura Other Current Liabilities?

Belluscura's other current liabilities for the quarter that ended in Jun. 2024 was £0.00 Mil.

Belluscura's quarterly other current liabilities increased from Jun. 2023 (£0.00 Mil) to Dec. 2023 (£1.76 Mil) but then declined from Dec. 2023 (£1.76 Mil) to Jun. 2024 (£0.00 Mil).

Belluscura's annual other current liabilities increased from Dec. 2021 (£0.13 Mil) to Dec. 2022 (£0.29 Mil) and increased from Dec. 2022 (£0.29 Mil) to Dec. 2023 (£1.76 Mil).

Belluscura Other Current Liabilities Historical Data

The historical data trend for Belluscura's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Belluscura Other Current Liabilities Chart

Belluscura Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Liabilities

Get a 7-Day Free Trial

Belluscura Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Other Current Liabilities	Get a 7-Day Free Trial						-	-	-	-	-

Belluscura Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Belluscura Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Belluscura's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Belluscura Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Belluscura PLC (LSE:BELL) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

15 Fetter Lane, Holborn, London, GBR, EC4A 1BW

Website

https://www.belluscura.com

Belluscura PLC is a medical device company. Its first product, the X-PLOR, is a lightweight FDA-cleared portable oxygen concentrator designed to replace larger, metal oxygen tanks and heavier portable oxygen concentrator devices. The company has only one operating segment being the sale of oxygen concentrators in the United States. The X-PLO2R weighs less than 1.5kg (3.25 lbs) and it is the first modular portable oxygen concentrator it will generate more oxygen by weight than any other FDA-cleared POC in its class. It either owns or exclusively licenses a total of 26 patents and applications relating to oxygen enrichment devices and treatments.

Belluscura Headlines

No Headlines